Showing results (31-40 of 45) with videos related to
Sort By:
Pageof 5
Environmental Research, Health : ERH|March 27, 2026
Characterizing household air pollutant concentrations associated with an electrification program in the rural San Joaquin ValleyMichael Johnson, Katherine A Kearns, Jesus Rivera, et al.Gerontology & Geriatric Medicine|September 16, 2017
Physical Activity Protects Men but Not Women for Sarcopenia DevelopmentJose de Jesus Rivera, Miguel Angel Fonseca-Sanchez, Patricia Rodriguez, et al.Gastroenterology|July 14, 2005
Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel diseaseMasaru Odashima, Giorgos Bamias, Jesus Rivera-Nieves, et al.Journal of Neuroscience Methods|June 19, 2021
Moving back in the brain to drive the field forward: Targeting neurostimulation to different brain regions in animal models of depression and neurodegenerationMichelle R Madore, Eugenia Poh, Samuel John Bollard, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2019
Should We Divide Crohn's Disease Into Ileum-Dominant and Isolated Colonic Diseases?Parambir S Dulai, Siddharth Singh, Niels Vande Casteele, et al.Immunohorizons|December 16, 2021
Class Ib MHC-Mediated Immune Interactions Play a Critical Role in Maintaining Mucosal Homeostasis in the Mammalian Large IntestineSuryasarathi Dasgupta, Igor Maricic, Jay Tang, et al.Nature Ecology & Evolution|August 17, 2017
A submarine volcanic eruption leads to a novel microbial habitatRoberto Danovaro, Miquel Canals, Michael Tangherlini, et al.Nature Ecology & Evolution|August 17, 2017
Corrigendum: A submarine volcanic eruption leads to a novel microbial habitatRoberto Danovaro, Miquel Canals, Michael Tangherlini, et al.Therapeutic Advances in Gastroenterology|November 26, 2020
Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn's diseaseAriela K Holmer, Robert Battat, Parambir S Dulai, et al.Inflammatory Bowel Diseases|October 9, 2018
Biomarkers Are Associated With Clinical and Endoscopic Outcomes With Vedolizumab Treatment in Ulcerative ColitisRobert Battat, Parambir S Dulai, Niels Vande Casteele, et al.Pageof 5